---
title: "A Study of Nemtabrutinib Plus Venetoclax vs Venetoclax + Rituximab (VR) in Second-line (2L) + Relapsed/​Refractory (R/​R) Chronic Lymphocytic Leukemia/​Small Lymphocytic Lymphoma (CLL/​SLL) (MK-1026-010/​BELLWAVE-010)"
canonical: "https://www.renown.org/clinical-trials-directory/NCT05947851"
last_updated: "2026-07-22T17:54:28Z"
---

# A Study of Nemtabrutinib Plus Venetoclax vs Venetoclax + Rituximab (VR) in Second-line (2L) + Relapsed/​Refractory (R/​R) Chronic Lymphocytic Leukemia/​Small Lymphocytic Lymphoma (CLL/​SLL) (MK-1026-010/​BELLWAVE-010)

URL: https://www.renown.org/clinical-trials-directory/NCT05947851

Short Title: MK1026-010

Enrollment Status: Recruiting

NCT #: [NCT05947851](https://clinicaltrials.gov/study/NCT05947851)

Specialty Area: Oncology

Condition Studied: Relapsed or Refractory Chronic Lymphocytic Leukemia / Small Lymphocytic Lymphoma (CLL/SLL)

Age Groups: Adult; Older Adult

Sex: All

Study Type: Interventional

Accepts Healthy Volunteers: No

Phase: II

Principal Investigator: Harry Menon DO, MPH

Complete Study Details: https://clinicaltrials.gov/study/NCT05947851

## Study Information

### Summary / Purpose

This study is looking at new treatment combinations for people with Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma (CLL/SLL) who have already received at least one prior treatment. The goal of the study is to compare these treatments and determine which approach may be more effective for managing the disease.

### Who Can Participate

Confirmed Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma (CLL/SLL) whose disease has returned or not responded after at least one prior treatment.

### What's Involved

Completing a screening process that includes medical history review, physical exams, blood tests, and possibly imaging scans to confirm eligibility.

## Additional Information

Location: Renown Health, Office of Clinical Research

Address: 1500 E 2nd St. Reno, NV 89502

General Research: [775-982-3646](tel:775-982-3646)

Oncology Research: [775-982-5050](tel:775-982-5050)

Email: [Renown-CRD@renown.org](mailto:Renown-CRD@renown.org)
